Arterial hypertension assessed “out-of-office” in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated “white coat” phenomenon
暂无分享,去创建一个
G. Kitas | C. Pitsavos | P. Sfikakis | E. Zampeli | A. Protogerou | A. Argyris | D. Panagiotakos | G. Konstantonis | K. Arida
[1] R. Schmieder,et al. Are physicians underestimating the challenges of hypertension management? Results from the Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey , 2013, European journal of preventive cardiology.
[2] Kunihiko Hayashi,et al. Independent association between age at natural menopause and hypercholesterolemia, hypertension, and diabetes mellitus: Japan nurses' health study. , 2013, Journal of atherosclerosis and thrombosis.
[3] K. Liao,et al. Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis. , 2013, Rheumatology.
[4] G. Kitas,et al. Myocardial ischaemia without obstructive coronary artery disease in rheumatoid arthritis : hypothesis-generating insights from a cross-sectional study , 2012 .
[5] Z. Yiğit,et al. Central aortic blood pressure and augmentation index during normal pregnancy , 2012, Hypertension Research.
[6] Janneke Tekstra,et al. Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis , 2012, Annals of Internal Medicine.
[7] M. Szklo,et al. Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis. , 2012, Seminars in arthritis and rheumatism.
[8] C. Turesson,et al. Early menopause is an independent predictor of rheumatoid arthritis , 2011, Annals of the rheumatic diseases.
[9] P. Sfikakis,et al. A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis. , 2011, Atherosclerosis.
[10] D. Carroll,et al. Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis , 2011, Journal of Human Hypertension.
[11] M. Szklo,et al. Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis. , 2011, Arthritis and rheumatism.
[12] J. Banegas,et al. Abnormalities in ambulatory blood pressure monitoring in hypertensive patients with diabetes , 2011, Hypertension Research.
[13] P. Sarafidis. Epidemiology of Resistant Hypertension , 2011, Journal of clinical hypertension.
[14] G. Stergiou,et al. Automated determination of the ankle-brachial index using an oscillometric blood pressure monitor: validation vs. Doppler measurement and cardiovascular risk factor profile , 2011, Hypertension Research.
[15] J. Olesen,et al. Extended Report , 2022 .
[16] S. Gabriel,et al. Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives , 2010, Annals of the rheumatic diseases.
[17] B Waeber,et al. European Society of Hypertension Practice Guidelines for home blood pressure monitoring , 2010, Journal of Human Hypertension.
[18] B. Dijkmans,et al. Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial , 2010, Annals of the rheumatic diseases.
[19] H. John,et al. Target organ damage in patients with rheumatoid arthritis: the role of blood pressure and heart rate. , 2010, Atherosclerosis.
[20] D. Symmons,et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis , 2009, Annals of the rheumatic diseases.
[21] G. Kitas,et al. Atherosclerosis in Rheumatoid Arthritis Versus Diabetes: A Comparative Study , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[22] A. Nevill,et al. Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[23] J. Blacher,et al. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study. , 2009, Journal of the American College of Cardiology.
[24] G. Kitas,et al. Galectin-2 (LGALS2) 3279C/T Polymorphism may be Independently Associated with Diastolic Blood Pressure in Patients with Rheumatoid Arthritis , 2009, Clinical and experimental hypertension.
[25] Mohsen Sadatsafavi,et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. , 2008, Arthritis and rheumatism.
[26] G. Stergiou,et al. Validation of the Microlife Watch BP Office professional device for office blood pressure measurement according to the International protocol , 2008, Blood pressure monitoring.
[27] G. Kitas,et al. Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. , 2008, Rheumatology.
[28] G. Kitas,et al. Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis. , 2008, Endothelium : journal of endothelial cell research.
[29] Antonios,et al. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. , 2007, Rheumatology.
[30] A. Dominiczak,et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.
[31] G. Stergiou,et al. Validation of the Microlife WatchBP Home device for self home blood pressure measurement according to the International Protocol , 2007, Blood pressure monitoring.
[32] A. Dominiczak,et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.
[33] D. Panagiotakos,et al. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. , 2007, Preventive medicine.
[34] E. Kulinskaya,et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. , 2006, Rheumatology.
[35] K. Fotiadis,et al. Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study. , 2006, American journal of hypertension.
[36] P. Palatini,et al. Masked hypertension in adults , 2005, Blood pressure monitoring.
[37] A. Naska,et al. Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study. , 2004, International journal of epidemiology.
[38] S. Yusuf,et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.
[39] P. Sarafidis,et al. Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study , 2004, Journal of Human Hypertension.
[40] D. Panagiotakos,et al. Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study , 2003, BMC public health.
[41] D. Panagiotakos,et al. Status and management of hypertension in Greece: role of the adoption of a Mediterranean diet the Attica study , 2003, Journal of hypertension.
[42] D. Panagiotakos,et al. Status and management of hypertension in Greece: role of the adoption of a Mediterranean diet , 2003 .
[43] M. Tomšič,et al. Leflunomide and hypertension , 2002, Annals of the rheumatic diseases.
[44] G L Freeman,et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. , 2001, Arthritis and rheumatism.
[45] G. Stergiou,et al. Prevalence, awareness, treatment, and control of hypertension in Greece: the Didima study. , 1999, American journal of hypertension.
[46] F. Mee,et al. Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society protocol. , 1991, Journal of hypertension.
[47] A. Silman,et al. Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. , 1990, Annals of the rheumatic diseases.
[48] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.